Treatment & Availability
RIGVIR® is registered by the State Agency of Medicines of the Republic of Latvia, becoming the first approved oncolytic virotherapy medication.
Rigvir Group Address: Atlasa street 7C, Riga, Latvia, LV-1026 E-mail: pr@rigvir.com